Literature DB >> 20577787

Vehicle composition influence on the microneedle-enhanced transdermal flux of naltrexone hydrochloride.

Mikolaj Milewski1, Audra L Stinchcomb.   

Abstract

PURPOSE: Transdermal delivery of drugs is often limited by formidable barrier properties of stratum corneum (SC). Microneedles (MN) enable creation of transient microchannels in the SC and bypass this barrier. Many reports have focused on the great effectiveness of MN in improving percutaneous flux values of a variety of drugs over a large molecular size spectrum. The objective of the present study is to evaluate the influence of formulation on MN-enhanced transdermal transport of naltrexone hydrochloride (NTX HCl).
METHODS: A series of in vitro experiments employing binary mixtures of propylene glycol (PG) and water as vehicle were used with either MN-treated or untreated skin. A simple model taking into account two parallel flux values through intact skin and microchannels was used to analyze data.
RESULTS: Transdermal permeation of NTX HCl from different donor solutions indicated that PG-rich formulations greatly limited MN-enhanced transport but had a much smaller effect on transport through intact skin.
CONCLUSIONS: Diffusion through the microchannel pathway seems to be donor viscosity-related and follows the relationship predicted by the Stokes-Einstein equation as shown by linear dependence of flux on diffusivity of NTX in donor solutions.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20577787     DOI: 10.1007/s11095-010-0191-x

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  39 in total

1.  Visualization of the lipid barrier and measurement of lipid pathlength in human stratum corneum.

Authors:  P Talreja; N K Kleene; W L Pickens; T F Wang; G B Kasting
Journal:  AAPS PharmSci       Date:  2001

2.  Microfabricated needles for transdermal delivery of macromolecules and nanoparticles: fabrication methods and transport studies.

Authors:  Devin V McAllister; Ping M Wang; Shawn P Davis; Jung-Hwan Park; Paul J Canatella; Mark G Allen; Mark R Prausnitz
Journal:  Proc Natl Acad Sci U S A       Date:  2003-11-17       Impact factor: 11.205

3.  Coated microneedles for transdermal delivery.

Authors:  Harvinder S Gill; Mark R Prausnitz
Journal:  J Control Release       Date:  2006-10-24       Impact factor: 9.776

4.  Microelectrometric titration measurement of the pKa's and partition and drug distribution coefficients of narcotics and narcotic antagonists and their pH and temperature dependence.

Authors:  J J Kaufman; N M Semo; W S Koski
Journal:  J Med Chem       Date:  1975-07       Impact factor: 7.446

5.  Straight-chain naltrexone ester prodrugs: diffusion and concurrent esterase biotransformation in human skin.

Authors:  Audra L Stinchcomb; Peter W Swaan; Opinya Ekabo; Kathleen K Harris; Jennifer Browe; Dana C Hammell; Todd A Cooperman; Michael Pearsall
Journal:  J Pharm Sci       Date:  2002-12       Impact factor: 3.534

6.  Naltrexone and alcohol dependence. Role of subject compliance.

Authors:  J R Volpicelli; K C Rhines; J S Rhines; L A Volpicelli; A I Alterman; C P O'Brien
Journal:  Arch Gen Psychiatry       Date:  1997-08

7.  Action of penetration enhancers on human skin as assessed by the permeation of model drugs 5-fluorouracil and estradiol. I. Infinite dose technique.

Authors:  M Goodman; B W Barry
Journal:  J Invest Dermatol       Date:  1988-10       Impact factor: 8.551

8.  Enhancement of skin permeation of docetaxel: a novel approach combining microneedle and elastic liposomes.

Authors:  Yuqin Qiu; Yunhua Gao; Kejia Hu; Fang Li
Journal:  J Control Release       Date:  2008-05-02       Impact factor: 9.776

9.  Flux across [corrected] microneedle-treated skin is increased by increasing charge of naltrexone and naltrexol in vitro.

Authors:  Stan L Banks; Raghotham R Pinninti; Harvinder S Gill; Peter A Crooks; Mark R Prausnitz; Audra L Stinchcomb
Journal:  Pharm Res       Date:  2008-05-01       Impact factor: 4.200

10.  Human skin permeation of 3-O-alkyl carbamate prodrugs of naltrexone.

Authors:  Haranath K Vaddi; Stan L Banks; Jianhong Chen; Dana C Hammell; Peter A Crooks; Audra L Stinchcomb
Journal:  J Pharm Sci       Date:  2009-08       Impact factor: 3.534

View more
  12 in total

1.  In vitro permeation of a pegylated naltrexone prodrug across microneedle-treated skin.

Authors:  Mikolaj Milewski; Thirupathi Reddy Yerramreddy; Priyanka Ghosh; Peter A Crooks; Audra L Stinchcomb
Journal:  J Control Release       Date:  2010-06-04       Impact factor: 9.776

2.  Effect of surfactants and pH on naltrexone (NTX) permeation across buccal mucosa.

Authors:  Vishwas Rai; Hock S Tan; Bozena Michniak-Kohn
Journal:  Int J Pharm       Date:  2011-04-04       Impact factor: 5.875

3.  Microneedle-assisted percutaneous delivery of naltrexone hydrochloride in yucatan minipig: in vitro-in vivo correlation.

Authors:  Mikolaj Milewski; Kalpana S Paudel; Nicole K Brogden; Priyanka Ghosh; Stan L Banks; Dana C Hammell; Audra L Stinchcomb
Journal:  Mol Pharm       Date:  2013-09-23       Impact factor: 4.939

4.  Stability, cutaneous delivery, and antioxidant potential of a lipoic acid and α-tocopherol codrug incorporated in microemulsions.

Authors:  Siji Thomas; Camila S Vieira; Martha A Hass; Luciana B Lopes
Journal:  J Pharm Sci       Date:  2014-06-24       Impact factor: 3.534

5.  Flux of ionic dyes across microneedle-treated skin: effect of molecular characteristics.

Authors:  Yasmine A Gomaa; Martin J Garland; Fiona J McInnes; Ryan F Donnelly; Labiba K El-Khordagui; Clive G Wilson
Journal:  Int J Pharm       Date:  2012-08-30       Impact factor: 5.875

6.  Effect of formulation pH on transport of naltrexone species and pore closure in microneedle-enhanced transdermal drug delivery.

Authors:  Priyanka Ghosh; Nicole K Brogden; Audra L Stinchcomb
Journal:  Mol Pharm       Date:  2013-05-13       Impact factor: 4.939

7.  Diclofenac enables unprecedented week-long microneedle-enhanced delivery of a skin impermeable medication in humans.

Authors:  Nicole K Brogden; Stan L Banks; Leslie J Crofford; Audra L Stinchcomb
Journal:  Pharm Res       Date:  2013-06-13       Impact factor: 4.200

8.  In Vitro Skin Retention and Drug Permeation through Intact and Microneedle Pretreated Skin after Application of Propranolol Loaded Microemulsions.

Authors:  Megan N Kelchen; Nicole K Brogden
Journal:  Pharm Res       Date:  2018-10-09       Impact factor: 4.200

9.  Optimization of naltrexone diclofenac codrugs for sustained drug delivery across microneedle-treated skin.

Authors:  Priyanka Ghosh; DoMin Lee; Kyung Bo Kim; Audra L Stinchcomb
Journal:  Pharm Res       Date:  2013-08-14       Impact factor: 4.200

Review 10.  Microneedles for drug and vaccine delivery.

Authors:  Yeu-Chun Kim; Jung-Hwan Park; Mark R Prausnitz
Journal:  Adv Drug Deliv Rev       Date:  2012-05-01       Impact factor: 15.470

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.